Fineline Cube

Follow:
14485 Articles
Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval to Test SHR-1681 in Clinical Trials
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval to Test SHR-1681 in Clinical Trials

CSPC Pharmaceutical's SYH9017 Receives NMPA Clearance for Weight Management Clinical Trial
CompanyDrug

CSPC Pharmaceutical’s SYH9017 Receives NMPA Clearance for Weight Management Clinical Trial

CSPC Pharmaceutical Group Receives NMPA Approval for Two Antibody-Drug Conjugates
CompanyDrug

CSPC Pharmaceutical Group Receives NMPA Approval for Two Antibody-Drug Conjugates

CanSino Biologics Initiates Phase I/II Study for CS-2036 Polio Vaccine with Gates Foundation Support
CompanyDrug

CanSino Biologics Initiates Phase I/II Study for CS-2036 Polio Vaccine with Gates Foundation Support

Innovent Biologics' Taletrectinib Wins NMPA Approval for ROS1+ NSCLC Treatment
CompanyDrug

Innovent Biologics’ Taletrectinib Wins NMPA Approval for ROS1+ NSCLC Treatment

MicroPort Scientific Corp. Receives NMPA Approval for FireRaptor Coronary Atherectomy System
CompanyMedical Device

MicroPort Scientific Corp. Receives NMPA Approval for FireRaptor Coronary Atherectomy System

Biopharma Company TransThera Sciences (Nanjing) Gets Green Light for HK IPO
Company

Biopharma Company TransThera Sciences (Nanjing) Gets Green Light for HK IPO

YolTech Therapeutics' YOLT-201 Advances in ATTR Treatment Clinical Trial
CompanyDrug

YolTech Therapeutics’ YOLT-201 Advances in ATTR Treatment Clinical Trial

Wuhan Weike Medical Technology Secures Series C Funding to Boost Cardiovascular Innovation
CompanyDeals

Wuhan Weike Medical Technology Secures Series C Funding to Boost Cardiovascular Innovation

Sumitomo Pharma Expands Collaboration with Shanghai Pharmaceutical for Prescription Drug Co-Marketing
CompanyDeals

Sumitomo Pharma Expands Collaboration with Shanghai Pharmaceuticals for Prescription Drug Co-Marketing

Boston Scientific's Next-Gen IVUS System AVVIGO+ Approved by China's NMPA for Coronary Disease Use
CompanyMedical Device

Boston Scientific’s Next-Gen IVUS System AVVIGO+ Approved by China’s NMPA for Coronary Disease Use

Guardant Health and Boehr Ingelheim Join Forces to Develop Guardant360 CDx for Zongertinib Companion Diagnostic
CompanyDeals

Guardant Health and Boehringer Ingelheim Join Forces to Develop Guardant360 CDx for Zongertinib Companion Diagnostic